PLASVET Trademark

Trademark Overview

On Friday, July 6, 2012, a trademark application was filed for PLASVET with the United States Patent and Trademark Office. The USPTO has given the PLASVET trademark a serial number of 85670600. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 2, 2015. This trademark is owned by Bioniche Life Sciences Inc.. The PLASVET trademark is filed in the Pharmaceutical Products category with the following description:

blood plasma administered enterally or parentally for fluid volume replacement; blood-derived product namely blood proteins for veterinary use administered enterally or parentally for blood volume expansion; blood derived pharmaceutical preparations namely, plasma factor supplementation for veterinary use, amino acids, proteins, carbohydrates and lipids for treatment of deficiencies, for the treatment of immune system disorders and deficiencies, and for the modulation of the immune system in animals
plasvet

General Information

Serial Number85670600
Word MarkPLASVET
Filing DateFriday, July 6, 2012
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, December 2, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesblood plasma administered enterally or parentally for fluid volume replacement; blood-derived product namely blood proteins for veterinary use administered enterally or parentally for blood volume expansion; blood derived pharmaceutical preparations namely, plasma factor supplementation for veterinary use, amino acids, proteins, carbohydrates and lipids for treatment of deficiencies, for the treatment of immune system disorders and deficiencies, and for the modulation of the immune system in animals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 13, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioniche Life Sciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBelleville, Ontario K8N1E2
CA

Trademark Events

Event DateEvent Description
Wednesday, December 2, 2015ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, December 2, 2015ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, April 30, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, April 30, 2015INQUIRY TO SUSPENSION E-MAILED
Thursday, April 30, 2015SUSPENSION INQUIRY WRITTEN
Thursday, October 30, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 24, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 24, 2014LETTER OF SUSPENSION E-MAILED
Thursday, April 24, 2014SUSPENSION LETTER WRITTEN
Thursday, April 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 10, 2014ASSIGNED TO LIE
Friday, March 28, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, October 29, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 29, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 30, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, September 30, 2013INQUIRY TO SUSPENSION E-MAILED
Monday, September 30, 2013SUSPENSION INQUIRY WRITTEN
Friday, March 22, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, March 22, 2013LETTER OF SUSPENSION E-MAILED
Friday, March 22, 2013SUSPENSION LETTER WRITTEN
Thursday, March 21, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 21, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 21, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 12, 2012NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, October 12, 2012PRIORITY ACTION E-MAILED
Friday, October 12, 2012PRIORITY ACTION WRITTEN
Wednesday, October 3, 2012ASSIGNED TO EXAMINER
Friday, July 13, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 10, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

plasvet blood namely deficiencies proteins veterinary system derived treatment administered plasma